Cell Signaling Technology

XPC (D1M5Y) Rabbit Monoclonal Antibody

#14768 · $161,351

66

Evidence Score · Well-Established

Used by 148 independent labs across 187 papers. How we score this →

87

Citing papers

2.6k

Combined citations

Supplier page Find this product

Research areas

Lung Cancer Treatments and Mutations24 HER2/EGFR in Cancer Research15 Lung Cancer Research Studies7 Cytokine Signaling Pathways and Interactions7 Autophagy in Disease and Therapy6 Monoclonal and Polyclonal Antibodies Research5 MicroRNA in disease regulation5 Cancer-related Molecular Pathways4

Papers citing this product

1

Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer

Nature Communications·2017·409 cit.·DOI

2

Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis

Cell Metabolism·2023·329 cit.·DOI

3

Gilteritinib overcomes lorlatinib resistance in ALK-rearranged cancer

Nature Communications·2021·100 cit.·DOI

4

Effects of Mild Cold Shock (25°C) Followed by Warming Up at 37°C on the Cellular Stress Response

PLoS ONE·2013·98 cit.·DOI

5

Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17

Scientific Reports·2016·95 cit.·DOI

6

The protective role of DOT1L in UV-induced melanomagenesis

Nature Communications·2018·82 cit.·DOI

7

Long-term characterization of activated microglia/macrophages facilitating the development of experimental brain metastasis through intravital microscopic imaging

Journal of Neuroinflammation·2019·79 cit.·DOI

8

A Disintegrin and Metalloprotease 17 Dynamic Interaction Sequence, the Sweet Tooth for the Human Interleukin 6 Receptor

Journal of Biological Chemistry·2014·73 cit.·DOI

9

BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung Cancer

Clinical Cancer Research·2023·72 cit.·DOI

10

Activation of Toll-like Receptor 2 (TLR2) induces Interleukin-6 trans-signaling

Scientific Reports·2019·64 cit.·DOI

Similar products

Product	Vendor	Evidence	Price	Papers
XPC AntibodyRabbit	Cell Signaling Technology	66	$136,317	100

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.